The Promise of Nanomedicine: Applications in Drug Delivery, Imaging, and Disease Diagnosis
DOI:
https://doi.org/10.36676/ssjmra.v1.i4.25Keywords:
Nanomedicine, Drug delivery, Imaging, Disease diagnosis, NanoparticlesAbstract
Nanomedicine, an interdisciplinary field at the intersection of nanotechnology and medicine, holds great promise for revolutionizing healthcare by enabling precise diagnostic and therapeutic interventions at the nanoscale level. With the ability to engineer nanoparticles with tailored properties, such as size, shape, surface chemistry, and payload encapsulation, nanomedicine offers innovative solutions for overcoming biological barriers, enhancing drug delivery efficiency, and improving imaging modalities for disease diagnosis. In this review, we explore the diverse applications of nanomedicine across three key areas: drug delivery, imaging, and disease diagnosis. We discuss the design principles and fabrication techniques of nanocarriers for targeted drug delivery, highlighting recent advances in nanoparticle-based formulations for cancer therapy, infectious disease treatment, and regenerative medicine. Furthermore, we examine the utility of nanoparticles as contrast agents in various imaging modalities, including magnetic resonance imaging (MRI), computed tomography (CT), and fluorescence imaging, for non-invasive visualization of anatomical structures and pathological processes. Additionally, we elucidate the role of nanotechnology in developing sensitive and specific diagnostic platforms for early disease detection, biomarker detection, and monitoring of therapeutic responses. Despite the tremendous potential of nanomedicine, several challenges remain, including concerns regarding nanoparticle toxicity, immunogenicity, and regulatory approval. Addressing these hurdles requires collaborative efforts among researchers, clinicians, regulatory agencies, and industry stakeholders to translate nanomedicine innovations from the laboratory to the clinic. By harnessing the power of nanotechnology, we can unlock new opportunities for personalized medicine, improve patient outcomes, and ultimately transform the landscape of healthcare delivery.
References
Blanco, E., Shen, H., & Ferrari, M. (2015). Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature biotechnology, 33(9), 941-951.
Jokerst, J. V., Gambhir, S. S., & Stanford, M. J. (2017). Near-infrared photoacoustic imaging in nanomedicine. Nano Today, 13, 11-14.
Hrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., ... & Bater, J. (2012). Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Science translational medicine, 4(128), 128ra39-128ra39.
Shi, J., & Kantoff, P. W. (2017). Cancer immunotherapy: moving beyond current vaccines. Nature medicine, 23(9), 1025-1026.
Weissleder, R., & Pittet, M. J. (2008). Imaging in the era of molecular oncology. Nature, 452(7187), 580-589.
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El-Sayed, M. A. (2012). The golden age: gold nanoparticles for biomedicine. Chemical Society Reviews, 41(7), 2740-2779.
Lee, D. E., Koo, H., & Sun, I. C. (2012). Multifunctional nanoparticles for multimodal imaging and theragnosis. Chemical Society Reviews, 41(7), 2656-2672.
Alkilany, A. M., & Murphy, C. J. (2010). Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?. Journal of nanoparticle research, 12(7), 2313-2333.
Farokhzad, O. C., & Langer, R. (2009). Impact of nanotechnology on drug delivery. ACS nano, 3(1), 16-20.
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature nanotechnology, 2(12), 751-760.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Shodh Sagar Journal for Medical Research Advancement
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.